A detailed history of Israel Englander (Millennium Management LLC) transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,894,176 shares of FOLD stock, worth $21.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,894,176
Previous 101,899 1758.88%
Holding current value
$21.3 Million
Previous $1.2 Million 1465.83%
% of portfolio
0.01%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$9.04 - $11.75 $16.2 Million - $21.1 Million
1,792,277 Added 1758.88%
1,894,176 $18.8 Million
Q1 2024

May 15, 2024

BUY
$11.43 - $14.24 $1.16 Million - $1.45 Million
101,899 New
101,899 $1.2 Million
Q2 2023

Aug 14, 2023

SELL
$10.72 - $13.3 $20 Million - $24.8 Million
-1,863,903 Reduced 96.15%
74,680 $937,000
Q1 2023

May 15, 2023

BUY
$10.91 - $13.54 $16 Million - $19.9 Million
1,467,981 Added 311.94%
1,938,583 $21.5 Million
Q4 2022

Feb 14, 2023

BUY
$9.89 - $12.7 $4.16 Million - $5.35 Million
420,898 Added 846.81%
470,602 $5.75 Million
Q3 2022

Nov 14, 2022

SELL
$9.82 - $12.75 $2.12 Million - $2.75 Million
-215,509 Reduced 81.26%
49,704 $519,000
Q2 2022

Aug 15, 2022

BUY
$6.23 - $11.12 $1.07 Million - $1.91 Million
171,980 Added 184.46%
265,213 $2.85 Million
Q1 2022

May 16, 2022

BUY
$7.89 - $12.48 $161,271 - $255,091
20,440 Added 28.08%
93,233 $883,000
Q4 2021

Feb 14, 2022

SELL
$9.82 - $12.44 $1.61 Million - $2.04 Million
-164,166 Reduced 69.28%
72,793 $841,000
Q3 2021

Nov 15, 2021

BUY
$8.74 - $11.84 $1.66 Million - $2.25 Million
190,124 Added 405.94%
236,959 $2.26 Million
Q2 2021

Aug 16, 2021

BUY
$8.71 - $10.72 $407,932 - $502,071
46,835 New
46,835 $451,000
Q1 2021

May 17, 2021

SELL
$9.2 - $23.86 $511,216 - $1.33 Million
-55,567 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$13.47 - $24.89 $2.25 Million - $4.16 Million
-167,327 Reduced 75.07%
55,567 $1.28 Million
Q3 2020

Nov 16, 2020

SELL
$12.89 - $15.89 $8.13 Million - $10 Million
-630,429 Reduced 73.88%
222,894 $3.15 Million
Q2 2020

Aug 14, 2020

SELL
$8.86 - $15.69 $3.59 Million - $6.35 Million
-404,851 Reduced 32.18%
853,323 $12.9 Million
Q1 2020

May 14, 2020

SELL
$6.63 - $11.16 $3.69 Million - $6.21 Million
-556,387 Reduced 30.66%
1,258,174 $11.6 Million
Q4 2019

Feb 14, 2020

BUY
$7.48 - $10.75 $3.63 Million - $5.22 Million
485,220 Added 36.5%
1,814,561 $17.7 Million
Q3 2019

Nov 14, 2019

BUY
$8.02 - $13.25 $1.95 Million - $3.22 Million
242,659 Added 22.33%
1,329,341 $10.7 Million
Q2 2019

Aug 15, 2019

BUY
$10.96 - $14.4 $5.33 Million - $7 Million
486,281 Added 80.99%
1,086,682 $13.6 Million
Q2 2019

Aug 14, 2019

SELL
$10.96 - $14.4 $18.9 Million - $24.8 Million
-1,725,149 Reduced 74.18%
600,401 $32.6 Million
Q1 2019

May 14, 2019

BUY
$10.04 - $13.92 $20.1 Million - $27.9 Million
2,004,615 Added 624.62%
2,325,550 $31.6 Million
Q4 2018

Feb 14, 2019

BUY
$8.38 - $13.44 $2.69 Million - $4.31 Million
320,935 New
320,935 $3.08 Million
Q2 2018

Aug 14, 2018

SELL
$13.13 - $17.09 $8.71 Million - $11.3 Million
-663,272 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$13.76 - $17.12 $9.02 Million - $11.2 Million
-655,301 Reduced 49.7%
663,272 $9.98 Million
Q4 2017

Feb 14, 2018

BUY
$12.51 - $16.24 $16.5 Million - $21.4 Million
1,318,573
1,318,573 $19 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3.15B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.